PloS one · 2026
Prognostic value of cardiac magnetic resonance-derived global longitudinal strain in LGE-negative dilated cardiomyopathy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Tian-Yue, Lan Tian, Wang Ling-Li, Zheng Yu-Cong, Feng Xin-Yi, Wang Fei-Yao, Zhang Fan, Xu Hua-Yan, Liu Xi, Yang Zhi, Li Rui
Аннотация
BACKGROUND: Dilated cardiomyopathy (DCM) is a major cause of heart failure and sudden cardiac death (SCD), with a 5-year survival rate of approximately 45%-50%. Current risk stratification is predominantly dependent on left ventricular ejection fraction (LVEF), which has limited sensitivity and specificity. Hence, more effective biomarkers should be used in late gadolinium enhancement (LGE)-negative patients.
METHODS: A total of 378 consecutive patients with LGE-negative DCM were enrolled from four hospitals between December 2016 and December 2022. Cardiac magnetic resonance imaging-derived strain parameters (global radial strain, global circumferential strain, and global longitudinal strain [GLS]) were assessed against the primary (SCD and related events) and secondary (heart failure, appropriate implantable cardioverter-defibrillator therapy) endpoints. Internal validation was performed using stratified bootstrap resampling with Harrell's optimism correction to report the optimism-corrected C-index. Data were accessed for research purposes from 15/06/2023-30/12/2023, and all records were de-identified prior to analysis.
RESULTS: Over a median follow-up of 59.78 months, 35 (9.26%) and 72 (19.0%) patients presented with the primary and secondary endpoints, respectively. Based on the multivariate Cox analysis, GLS, LVEF, and age were independent prognostic factors. However, only GLS (HR = 1.37; P = 0.041) remained significant in the LVEF <20% subgroup. A model integrating GLS and LVEF had a better discrimination ability for SCD than LVEF strata alone (apparent C-index 0.756 vs 0.714, P < 0.001). This advantage persisted after bootstrap internal validation (B = 1000; optimism-corrected C-index 0.754 vs 0.711, Holm adjusted P = 0.048). Further inclusion of age and New York Heart Association (NYHA) classification enhanced the model's performance (model 4): apparent C-index 0.801; optimism-corrected C-index 0.785).
CONCLUSION: GLS is an independent predictor of SCD-related events in LGE-negative DCM. Incorporating GLS with conventional indicators such as age, NYHA classification, and LVEF significantly enhances prognostic discrimination and model robustness, indicating potential value for future clinical risk stratification.
METHODS: A total of 378 consecutive patients with LGE-negative DCM were enrolled from four hospitals between December 2016 and December 2022. Cardiac magnetic resonance imaging-derived strain parameters (global radial strain, global circumferential strain, and global longitudinal strain [GLS]) were assessed against the primary (SCD and related events) and secondary (heart failure, appropriate implantable cardioverter-defibrillator therapy) endpoints. Internal validation was performed using stratified bootstrap resampling with Harrell's optimism correction to report the optimism-corrected C-index. Data were accessed for research purposes from 15/06/2023-30/12/2023, and all records were de-identified prior to analysis.
RESULTS: Over a median follow-up of 59.78 months, 35 (9.26%) and 72 (19.0%) patients presented with the primary and secondary endpoints, respectively. Based on the multivariate Cox analysis, GLS, LVEF, and age were independent prognostic factors. However, only GLS (HR = 1.37; P = 0.041) remained significant in the LVEF <20% subgroup. A model integrating GLS and LVEF had a better discrimination ability for SCD than LVEF strata alone (apparent C-index 0.756 vs 0.714, P < 0.001). This advantage persisted after bootstrap internal validation (B = 1000; optimism-corrected C-index 0.754 vs 0.711, Holm adjusted P = 0.048). Further inclusion of age and New York Heart Association (NYHA) classification enhanced the model's performance (model 4): apparent C-index 0.801; optimism-corrected C-index 0.785).
CONCLUSION: GLS is an independent predictor of SCD-related events in LGE-negative DCM. Incorporating GLS with conventional indicators such as age, NYHA classification, and LVEF significantly enhances prognostic discrimination and model robustness, indicating potential value for future clinical risk stratification.